Blog

SNP Genotyping Services: When Does Outsourcing Make Sense?

SNP Genotyping Services: When Does Outsourcing Make Sense?

Single nucleotide polymorphism (SNP) analysis underpins modern genomics, from genomic selection in elite breeding programs to trait discovery in academic research and product development in biotech.

As demand for SNP data grows, so too do the questions around infrastructure, cost, scalability, and expertise.

For many organisations, the decision is no longer whether to genotype but whether to invest in building in-house capability or to partner with a specialist provider of genotyping services.

This article explores when outsourcing SNP genotyping, in full or in part, makes strategic, technical, and commercial sense, and how flexible service models can accelerate research and breeding outcomes.

The Expanding Role of SNP Genotyping

SNP genotyping supports:

  • Marker-assisted selection (MAS)
  • Genomic selection (GS)
  • Trait introgression
  • Parentage verification
  • Diversity analysis
  • QTL validation
  • Marker discovery
  • Regulatory or quality control testing

Whether you are an academic researcher, commercial breeder or biotech innovator, SNP data informs high-value biological and commercial decisions.

The challenge lies in generating that data efficiently, accurately, and at the right scale.

How the underlying assays work, and how allele-specific PCR compares with other methods, is covered in SNP genotyping assays

In-House Genotyping or Genotyping Services: A Quick Comparison

Before working through the individual scenarios, the trade-off in summary. The decisive question is rarely capability, it is utilisation: an in-house laboratory only pays for itself if it runs close to capacity year-round.

FactorIn-house laboratoryOutsourced genotyping services
Upfront investmentPCR instrumentation, extraction automation, plate readers, laboratory fit-outNone, project-based cost only
StaffingMolecular biology staff, data analysis expertise, ongoing trainingProvided by the service laboratory
Cost behaviourLargely fixed, independent of sample numbersVariable, scales with actual usage
Seasonal peaksCapacity sized to the peak sits idle the rest of the yearCapacity available on demand
Turnaround controlFull control, subject to internal capacityDepends on the provider’s queue and agreed service levels
Method flexibilityLimited to the platforms purchasedEndpoint PCR, multiplex and GBTS from one provider
Quality systemsMust be built and maintained internallyProvided, including validated workflows and QC
Best suited toHigh, steady sample volumes and long-term genomics strategyVariable volumes, new entrants to genomics, seasonal peaks, start-ups

When Does Outsourcing Genotyping Services Make Sense?

1. When You Don’t Have an In-House Molecular Lab

Many traditional plant and animal breeding organisations are moving into genomic selection for the first time.

Establishing a molecular lab requires:

  • Capital investment in PCR instrumentation and extraction automation
  • Validated workflows
  • Skilled molecular biology staff
  • Data analysis expertise
  • Ongoing consumables and maintenance
  • Quality management systems

For organisations without existing infrastructure, outsourcing to a specialist provider removes these barriers.

Example: A Plant Breeder Transitioning to Genomic Selection

A traditional plant breeder and seed producer wants to implement marker-assisted selection but has:

  • No molecular lab
  • No genomics team
  • Limited experience in SNP workflows

Rather than investing in infrastructure, the breeder partners with 3CR Bioscience for an integrated workflow:

  1. Field leaf sampling
  2. Shipment using 3CR’s secure collection kits
  3. Automated magnetic bead-based DNA extraction
  4. SNP genotyping
  5. Delivery of analysed, quality-controlled data

The collection kits and the sampling procedure are documented in the leaf sample collection kit user guide.

Breeders can choose:

  • Endpoint genotyping using PACE® chemistry for screening a defined set of SNP markers
  • PACE® Multiplex genotyping, enabling detection of up to four targets in a single reaction to increase throughput
  • Genotyping by Target Sequencing (GBTS) for higher-density marker analysis supporting genomic selection

The breeder focuses on making crossing and selection decisions, not managing laboratory workflows.

2. When You Need Seasonal Scalability

Example: Established Breeder with Peak-Season Bottlenecks

Large breeding companies often maintain internal genotyping labs. For much of the year, their in-house capacity is sufficient.

However, during peak growing seasons:

  • Marker screening demand spikes
  • Thousands of samples must be processed rapidly
  • Turnaround time directly affects crossing decisions

At these times, outsourcing part of the workload to a trusted partner offering high-throughput genotyping services becomes strategically valuable.

3CR Bioscience provides overflow capacity through:

  • High-throughput PACE® endpoint SNP genotyping
  • Large-scale automated DNA extraction services
  • GBTS for dense marker datasets

Rather than expanding permanent staff or purchasing additional instrumentation used only seasonally, breeders gain:

  • Rapid turnaround
  • Operational flexibility
  • Reduced internal pressure
  • Risk mitigation

Outsourcing becomes a strategic pressure valve rather than a permanent structural change.

3. When You Only Need Part of the Workflow

Outsourcing SNP genotyping does not need to be all-or-nothing. At 3CR Bioscience, researchers can select modular services, including:

  • DNA extraction only (purified DNA returned)
  • Endpoint genotyping only (customer supplies DNA)
  • Extraction + PACE® genotyping
  • Extraction + GBTS
  • GBTS only

This flexibility suits:

  • Universities performing in-house qPCR but lacking automated extraction
  • Research labs holding archived DNA stocks requiring SNP validation
  • Companies conducting internal bioinformatics analysis
  • Startups controlling costs through staged outsourcing

By selecting only what’s required, organisations maintain control while reducing operational burden.

All five service combinations, and what each one includes, are set out on the 3CR Bioscience genotyping services page.

4. When You Need High-Density Data Without Building NGS Capacity

Next-generation sequencing (NGS) infrastructure requires:

  • Library preparation optimisation
  • Sequencing platform access
  • Bioinformatics pipelines
  • Data storage and cloud infrastructure
  • Ongoing quality control

For many breeding and research programs, building internal NGS capacity is not part of the long term plan.

Genotyping by Target Sequencing (GBTS) offers targeted, cost-effective SNP discovery and genotyping across thousands of markers, without whole-genome sequencing overhead.

Through its GBTS service, 3CR Bioscience provides:

  • Standardised sample processing
  • Automated QC workflows
  • Library construction
  • Cloud-based data delivery

Researchers gain dense genomic data for selection or mapping, without managing sequencing facilities internally.

The general trade-off between targeted genotyping and sequencing is explained in genotyping vs sequencing.

PCR lab services

5. When Accuracy and Reproducibility Are Non-Negotiable

Reliable SNP calls depend on:

  • High-quality DNA extraction
  • Optimised chemistry
  • Robust assay design
  • Automated workflows
  • Stringent QC procedures

DNA Extraction

3CR’s automated magnetic bead-based extraction workflows deliver

  • High purity
  • Consistent yield
  • Compatibility with plant tissue, animal tissue, and blood

Endpoint Genotyping with PACE®

PACE chemistry provides:

  • Precise SNP discrimination
  • High call rates: 99.8%
  • Cost-effective marker screening
  • Scalability from small panels to thousands of samples

PACE® Multiplex further increases efficiency by enabling multiple SNP targets per reaction without additional optimisation.

Multiplex Genotyping with PACE Multiplex Master Mix

High-Density Genotyping with GBTS

GBTS enables

  • High-throughput marker screening
  • Targeted genomic region capture
  • Efficient sequencing utilisation
  • Scalable SNP genotyping for genomic selection

Selecting the right platform enables accuracy in line with program goals.

6. When Speed Impacts Commercial Outcomes

In breeding programs, delayed genotyping can mean:

  • Missed crossing windows
  • Slower trait introgression
  • Reduced genetic gain per cycle
  • Delayed product launch

In annual crops, a missed genotyping window may equate to a full year of delay.

Outsourcing to a specialist provider offering rapid, reliable SNP genotyping services protects timelines and competitive advantage.

Outsourcing removes this bottleneck. Working with a specialist genotyping provider, samples can move from receipt to report delivery in as little as 14 days, keeping pace with even the tightest breeding calendar.

Genotyping technology - wheat crop breeding genomics

Shipping timelines and packaging requirements, which affect total turnaround, are covered in the DNA sample shipping guide.

7. When You’re a Start-Up or Spin-Out

Early-stage biotech companies prioritise:

  • Lean operations
  • Flexible expenditure
  • Rapid proof-of-concept data
  • Capital preservation

Outsourcing genotyping allows startups to:

  • Access expert infrastructure
  • Avoid equipment purchase and depreciation
  • Scale projects as funding progresses
  • Focus internal resources on IP development and commercial strategy

Additional Situations Where Outsourcing Makes Strategic Sense

Beyond breeding and academia, outsourcing SNP genotyping supports:

  • Livestock parentage verification programs
  • Conservation genetics initiatives
  • Contract research organisations (CROs)
  • Regulatory compliance testing
  • Biotech product validation

In each case, specialist genotyping services reduce operational burden while maintaining high standards of data quality and reproducibility.

The Strategic Advantage of a Trusted Genotyping Partner

Outsourcing is not simply about cost; it is about:

  • Access to specialist technical expertise
  • Reliable, reproducible SNP data
  • Scalability on demand
  • Risk reduction
  • Faster decision-making
  • Innovation without infrastructure overhead

Through integrated DNA extraction services, PACE® endpoint and multiplex genotyping, and high-density GBTS solutions, 3CR Bioscience supports researchers and breeders in generating high-quality genomic data aligned with their scientific and commercial objectives.

Frequently Asked Questions About Genotyping Services

What are SNP genotyping services?

SNP genotyping services outsource part or all of the laboratory workflow to a specialist provider. A typical service covers DNA extraction, marker analysis by allele-specific PCR or targeted sequencing, quality control and delivery of analysed genotype data. Customers send samples and receive results, without operating the instrumentation themselves.

Can I outsource only part of my genotyping workflow?

Yes. Services are modular: DNA extraction only, endpoint genotyping only with customer-supplied DNA, extraction combined with PACE® genotyping, extraction combined with GBTS, or GBTS alone. Organisations commonly keep bioinformatics in house and outsource the wet-lab steps.

Is outsourcing cheaper than building an in-house genotyping lab?

It depends on utilisation. An in-house laboratory carries largely fixed costs in instrumentation, staff and quality systems, so it pays off at high and steady sample volumes. Outsourcing converts those fixed costs into variable project costs, which is usually cheaper for variable volumes, seasonal peaks and organisations new to genomics.

What sample types can be sent for genotyping?

3CR Bioscience’s extraction workflows handle plant tissue, animal tissue and blood. Customers who have already extracted DNA can send that instead and book genotyping only.

Final Thoughts: Focus on Your Science, Not Your Pipettes

The decision to outsource SNP genotyping should be guided by:

  • Project scale
  • Internal expertise
  • Seasonal demand
  • Capital constraints
  • Speed requirements
  • Long-term strategy

For many organisations, particularly those transitioning into genomics or managing peak workloads, outsourcing delivers measurable scientific and commercial advantage.

With flexible genotyping services and scalable technology platforms, 3CR Bioscience enables breeding programs, commercial production, and research teams to turn genetic insight into actionable outcomes, without the bottleneck of managing laboratory infrastructure.

Request a quote for your genotyping project , and receive a tailored quote within 24 hours. Teams that would rather run the work in house can compare reagents and instrumentation instead.

MORE POSTS

TURBO GRINDER USER GUIDE
Learn how to install, configure, operate and maintain the Turbo Grinder with step-by-step instructions, software setup, troubleshooting tips and best practices for reliable high-throughput sample homogenisation.
PACE® GENOTYPING MASTER MIX – USER GUIDE
Get everything you need to run successful PACE® genotyping reactions, from DNA and assay setup to thermal cycling, fluorescence detection and genotype interpretation.
PACE® NANO GENOTYPING MASTER MIX TRIAL KIT USER GUIDE
Everything you need to get started with PACE® Nano Genotyping—from reaction setup and ROX compatibility to endpoint detection and data interpretation—in one practical user guide.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Resolve Genotyping Challenges. With One Practical Guide.

From failed amplification to scattered cluster plots — this guide provides structured, expert-backed solutions for the 7 most common PACE® genotyping issues.

"(Required)" indicates required fields

This field is for validation purposes and should be left unchanged.
I’d like to sign up for the newsletter

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager

For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.

Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.

Daniel LawsonMarketing Manager
Daniel is a strategically minded marketing and communications professional with over a decade of experience delivering integrated, multi-channel campaigns across healthcare, legal and not-for-profit sectors. He has a strong track record in building brand visibility, driving engagement and supporting revenue growth through audience-focused marketing.
Prior to joining 3CR Bioscience in 2025, Daniel held senior marketing roles where he led strategic communications, managed brand development and delivered high-impact digital and content campaigns. His experience spans SEO, CRM, PR, events and stakeholder engagement, with a particular strength in translating complex messages into clear, compelling content.
At 3CR Bioscience, Daniel is responsible for shaping and executing the company’s marketing strategy, enhancing brand presence and supporting commercial growth through targeted, data-driven campaigns.